Roscovitine : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Roscovitine : Questions médicales les plus fréquentes", "headline": "Roscovitine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Roscovitine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-24", "dateModified": "2026-03-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Roscovitine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Purines", "url": "https://questionsmedicales.fr/mesh/D011687", "about": { "@type": "MedicalCondition", "name": "Purines", "code": { "@type": "MedicalCode", "code": "D011687", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.759" } } }, "about": { "@type": "MedicalCondition", "name": "Roscovitine", "alternateName": "Roscovitine", "code": { "@type": "MedicalCode", "code": "D000077546", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Laurent Meijer", "url": "https://questionsmedicales.fr/author/Laurent%20Meijer", "affiliation": { "@type": "Organization", "name": "ManRos Therapeutics, Presqu'île de Perharidy, 29680 Roscoff, France." } }, { "@type": "Person", "name": "Asif Rashid", "url": "https://questionsmedicales.fr/author/Asif%20Rashid", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR, People's Republic of China." } }, { "@type": "Person", "name": "Xin Duan", "url": "https://questionsmedicales.fr/author/Xin%20Duan", "affiliation": { "@type": "Organization", "name": "The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China." } }, { "@type": "Person", "name": "Feng Gao", "url": "https://questionsmedicales.fr/author/Feng%20Gao", "affiliation": { "@type": "Organization", "name": "The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China." } }, { "@type": "Person", "name": "Mengsu Yang", "url": "https://questionsmedicales.fr/author/Mengsu%20Yang", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR, People's Republic of China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Effects of activation with a Ca ionophore and roscovitine on the development of human oocytes that failed to fertilize after ICSI.", "datePublished": "2023-00-00", "url": "https://questionsmedicales.fr/article/37940514", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2152/jmi.70.321" } }, { "@type": "ScholarlyArticle", "name": "Tumor-Directed Therapeutic Targets in Cushing Disease.", "datePublished": "2019-03-01", "url": "https://questionsmedicales.fr/article/30535260", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1210/jc.2018-02080" } }, { "@type": "ScholarlyArticle", "name": "Treatment of Cushing Disease With Pituitary-Targeting Seliciclib.", "datePublished": "2023-02-15", "url": "https://questionsmedicales.fr/article/36214832", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1210/clinem/dgac588" } }, { "@type": "ScholarlyArticle", "name": "Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial.", "datePublished": "2020-Jun-26", "url": "https://questionsmedicales.fr/article/32590730", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MD.0000000000020458" } }, { "@type": "ScholarlyArticle", "name": "Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization.", "datePublished": "2019-01-10", "url": "https://questionsmedicales.fr/article/30321399", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/nar/gky935" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Purines", "item": "https://questionsmedicales.fr/mesh/D011687" }, { "@type": "ListItem", "position": 6, "name": "Roscovitine", "item": "https://questionsmedicales.fr/mesh/D000077546" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Roscovitine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Roscovitine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-06-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Roscovitine", "description": "Comment la roscovitine est-elle diagnostiquée ?\nQuels tests sont utilisés pour évaluer l'effet de la roscovitine ?", "url": "https://questionsmedicales.fr/mesh/D000077546#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Roscovitine", "description": "Quels sont les effets secondaires de la roscovitine ?\nLa roscovitine provoque-t-elle des symptômes neurologiques ?", "url": "https://questionsmedicales.fr/mesh/D000077546#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Roscovitine", "description": "La roscovitine peut-elle prévenir le cancer ?\nQuels modes de vie peuvent compléter l'effet de la roscovitine ?", "url": "https://questionsmedicales.fr/mesh/D000077546#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Roscovitine", "description": "La roscovitine est-elle utilisée pour traiter le cancer ?\nComment la roscovitine agit-elle sur les cellules cancéreuses ?", "url": "https://questionsmedicales.fr/mesh/D000077546#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Roscovitine", "description": "Quelles complications peuvent survenir avec la roscovitine ?\nLa roscovitine peut-elle interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D000077546#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Roscovitine", "description": "Qui est à risque d'effets secondaires de la roscovitine ?\nLes personnes âgées sont-elles plus à risque avec la roscovitine ?", "url": "https://questionsmedicales.fr/mesh/D000077546#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment la roscovitine est-elle diagnostiquée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La roscovitine n'est pas un médicament diagnostique, mais un agent de recherche." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'effet de la roscovitine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests in vitro et in vivo mesurent l'inhibition des kinases et l'apoptose." } }, { "@type": "Question", "name": "Quels sont les effets secondaires de la roscovitine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure fatigue, nausées et troubles gastro-intestinaux." } }, { "@type": "Question", "name": "La roscovitine provoque-t-elle des symptômes neurologiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes neurologiques peuvent survenir, mais ils sont rares et dépendent de la dose." } }, { "@type": "Question", "name": "La roscovitine peut-elle prévenir le cancer ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des études préliminaires suggèrent qu'elle pourrait avoir un effet préventif, mais ce n'est pas prouvé." } }, { "@type": "Question", "name": "Quels modes de vie peuvent compléter l'effet de la roscovitine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation saine et l'exercice régulier peuvent soutenir les traitements anticancéreux." } }, { "@type": "Question", "name": "La roscovitine est-elle utilisée pour traiter le cancer ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est étudiée comme traitement potentiel pour divers types de cancer." } }, { "@type": "Question", "name": "Comment la roscovitine agit-elle sur les cellules cancéreuses ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle inhibe les kinases, ce qui bloque la prolifération cellulaire et induit l'apoptose." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la roscovitine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles hématologiques peuvent survenir, nécessitant une surveillance." } }, { "@type": "Question", "name": "La roscovitine peut-elle interagir avec d'autres médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut interagir avec d'autres traitements, augmentant le risque d'effets indésirables." } }, { "@type": "Question", "name": "Qui est à risque d'effets secondaires de la roscovitine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les patients avec des antécédents de maladies hépatiques ou rénales sont à risque accru." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque avec la roscovitine ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent avoir une tolérance réduite et un risque accru d'effets secondaires." } } ] } ] }